Organon & Co. (OGN) Short Interest Ratio & Short Volume $15.39 -0.30 (-1.91%) As of 10:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Organon & Co. Short Interest DataOrganon & Co. (OGN) has a short interest of 16.58 million shares, representing 6.46% of the float (the number of shares available for trading by the public). This marks a -9.05% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.1, indicating that it would take 5.1 days of the average trading volume of 2.76 million shares to cover all short positions.Current Short Interest16,580,000 sharesPrevious Short Interest18,230,000 sharesChange Vs. Previous Month-9.05%Dollar Volume Sold Short$258.40 millionShort Interest Ratio5.1 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares257,540,000 sharesFloat Size256,700,000 sharesShort Percent of Float6.46%Today's Trading Volume440,806 sharesAverage Trading Volume2,761,671 sharesToday's Volume Vs. Average16% Short Selling Organon & Co.? Sign up to receive the latest short interest report for Organon & Co. and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOGN Short Interest Over TimeOGN Days to Cover Over TimeOGN Percentage of Float Shorted Over Time Organon & Co. Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202516,580,000 shares $258.40 million -9.1%6.5%5.1 $15.59 1/15/202518,230,000 shares $286.58 million -0.6%7.1%5.4 $15.72 12/31/202418,340,000 shares $273.63 million +20.1%7.1%5.6 $14.92 12/15/202415,270,000 shares $233.63 million +11.6%5.9%4.8 $15.30 11/30/202413,680,000 shares $217.10 million -7.1%5.3%5.5 $15.87 11/15/202414,720,000 shares $221.17 million +4.0%5.7%6.3 $15.03 10/31/202414,150,000 shares $265.81 million +12.9%5.5%6.6 $18.79 10/15/202412,530,000 shares $226.04 million +28.3%4.9%6.5 $18.04 9/30/20249,770,000 shares $186.80 million +25.9%3.8%5.3 $19.12 9/15/20247,760,000 shares $158.85 million -0.5%3.0%4.6 $20.47 Get the Latest News and Ratings for OGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organon & Co. and its competitors with MarketBeat's FREE daily newsletter. 8/31/20247,800,000 shares $174.33 million -10.2%3.0%4.7 $22.35 8/15/20248,690,000 shares $175.71 million +10.6%3.4%5.2 $20.22 7/31/20247,860,000 shares $171.74 million -5.1%3.1%4.7 $21.85 7/15/20248,280,000 shares $171.81 million +4.2%3.2%4.9 $20.75 6/30/20247,950,000 shares $164.57 million -0.1%3.1%4.3 $20.70 6/15/20247,960,000 shares $162.38 million -1.4%3.1%4.2 $20.40 5/31/20248,070,000 shares $172.13 million -0.5%3.1%4 $21.33 5/15/20248,110,000 shares $175.58 million -32.9%3.2%3.8 $21.65 4/30/202412,090,000 shares $224.99 million +10.5%4.7%5.1 $18.61 4/15/202410,940,000 shares $193.75 million +0.1%4.3%4.7 $17.71 3/31/202410,930,000 shares $205.48 million +7.9%4.3%4 $18.80 3/15/202410,130,000 shares $185.18 million +4.3%4.0%3.4 $18.28 2/29/20249,710,000 shares $169.05 million -27.2%3.8%2.7 $17.41 2/15/202413,340,000 shares $248.39 million +8.2%5.2%3.4 $18.62 1/31/202412,330,000 shares $205.29 million -10.7%4.8%3 $16.65 1/15/202413,810,000 shares $231.32 million -27.8%5.4%3 $16.75 12/31/202319,120,000 shares $275.71 million +5.8%7.5%3.4 $14.42 12/15/202318,070,000 shares $236.36 million +25.8%7.1%3.3 $13.08 11/30/202314,370,000 shares $162.67 million -1.7%5.6%2.9 $11.32 11/15/202314,620,000 shares $169.01 million +36.3%5.7%3.2 $11.56 10/31/202310,730,000 shares $158.70 million -3.3%4.2%2.5 $14.79 10/15/202311,100,000 shares $192.25 million +10.9%4.4%3 $17.32 9/30/202310,010,000 shares $173.77 million +37.9%3.9%4.1 $17.36 9/15/20237,260,000 shares $141.86 million +4.3%2.8%3.3 $19.54 8/31/20236,960,000 shares $152.84 million -0.9%2.7%3.3 $21.96 8/15/20237,020,000 shares $163.29 million +12.9%2.8%3.3 $23.26 7/31/20236,220,000 shares $136.72 million -7.2%2.4%2.7 $21.98 7/15/20236,700,000 shares $137.48 million -8.3%2.6%3.2 $20.52 6/30/20237,310,000 shares $152.12 million +5.5%2.9%3.6 $20.81 6/15/20236,930,000 shares $144.94 million -4.4%2.7%3.5 $20.92We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol 5/31/20237,250,000 shares $140.58 million +5.1%2.9%3.5 $19.39 5/15/20236,900,000 shares $143.80 million +11.7%2.7%3.3 $20.84 4/30/20236,180,000 shares $152.21 million -8.9%2.4%3 $24.63 4/15/20236,780,000 shares $161.36 million -1.2%2.7%3.4 $23.80 3/31/20236,860,000 shares $161.35 million +7.4%2.7%3.2 $23.52 3/15/20236,390,000 shares $137.51 million -12.2%2.5%3 $21.52 2/28/20237,280,000 shares $178.29 million +31.7%2.9%3.4 $24.49 2/15/20235,530,000 shares $161.81 million +15.9%2.2%2.7 $29.26 1/31/20234,770,000 shares $143.72 million -22.6%1.9%2.5 $30.13 1/15/20236,160,000 shares $197.49 million -14.2%2.4%3 $32.06 12/30/20227,180,000 shares $200.54 million +4.5%2.8%3.6 $27.93 12/15/20226,870,000 shares $194.28 million +16.4%2.7%3.4 $28.28 11/30/20225,900,000 shares $153.52 million +7.1%2.3%3 $26.02 11/15/20225,510,000 shares $137.09 million -3.0%2.2%2.9 $24.88 10/31/20225,680,000 shares $148.70 million -1.7%2.2%3 $26.18 10/15/20225,780,000 shares $134.73 million -4.3%2.3%3.2 $23.31 9/30/20226,040,000 shares $141.34 million +1.7%2.4%3.5 $23.40 9/15/20225,940,000 shares $170.78 million +12.3%2.3%3.8 $28.75 8/31/20225,290,000 shares $150.92 million -2.6%2.1%3.5 $28.53 8/15/20225,430,000 shares $168.38 million -2.9%2.1%3.7 $31.01 7/31/20225,590,000 shares $177.31 million +1.6%2.2%3.7 $31.72 7/15/20225,500,000 shares $175.84 million -4.7%2.2%3.6 $31.97 6/30/20225,770,000 shares $194.74 million -8.1%2.3%3.8 $33.75 6/15/20226,280,000 shares $210.95 million -1.3%2.5%4 $33.59 5/31/20226,360,000 shares $241.43 million -17.0%2.5%3.5 $37.96 5/15/20227,660,000 shares $267.64 million +14.7%3.0%3.7 $34.94 4/30/20226,680,000 shares $215.96 million -2.6%2.6%3.1 $32.33 4/15/20226,860,000 shares $239.41 million +16.7%2.7%3.1 $34.90 3/31/20225,880,000 shares $205.39 million -0.2%2.3%2.6 $34.93 3/15/20225,890,000 shares $190.19 million +6.9%2.3%2.6 $32.29 2/28/20225,510,000 shares $205.69 million +11.5%2.2%2.6 $37.33 2/15/20224,940,000 shares $173.99 million +14.1%2.0%2.4 $35.22 1/31/20224,330,000 shares $138.17 million +20.6%1.8%2 $31.91 1/15/20223,590,000 shares $117.97 million -5.3%1.4%1.7 $32.86 12/31/20213,790,000 shares $115.41 million -12.5%1.5%1.9 $30.45 12/15/20214,330,000 shares $127.00 million +6.9%1.7%2.1 $29.33 11/30/20214,050,000 shares $118.38 million +33.2%1.6%2.1 $29.23 11/15/20213,040,000 shares $101.48 million -25.7%1.2%1.6 $33.38 10/29/20214,090,000 shares $150.31 million -7.5%1.6%2.1 $36.75 10/15/20214,420,000 shares $154.21 million +14.5%1.7%2.2 $34.89 9/30/20213,860,000 shares $126.57 million -9.8%1.5%1.9 $32.79 9/15/20214,280,000 shares $144.32 million +4.4%1.7%1.8 $33.72 8/31/20214,100,000 shares $138.95 million -22.2%1.6%1.3 $33.89 8/13/20215,270,000 shares $180.29 million No Change2.1%1.4 $34.21 OGN Short Interest - Frequently Asked Questions What is Organon & Co.'s current short interest? Short interest is the volume of Organon & Co. shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 16,580,000 shares of OGN short. 6.46% of Organon & Co.'s shares are currently sold short. Learn More on Organon & Co.'s current short interest. What is a good short interest ratio for Organon & Co.? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OGN shares currently have a short interest ratio of 5.0. Learn More on Organon & Co.'s short interest ratio. Which institutional investors are shorting Organon & Co.? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Organon & Co.: Wolverine Trading LLC, Group One Trading LLC, D. E. Shaw & Co. Inc., Citadel Advisors LLC, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Simplex Trading LLC, Wolverine Asset Management LLC, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Organon & Co.? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.46% of Organon & Co.'s floating shares are currently sold short. Is Organon & Co.'s short interest increasing or decreasing? Organon & Co. saw a decline in short interest during the month of January. As of January 31st, there was short interest totaling 16,580,000 shares, a decline of 9.1% from the previous total of 18,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Organon & Co.'s float size? Organon & Co. currently has issued a total of 257,540,000 shares. Some of Organon & Co.'s outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Organon & Co. currently has a public float of 256,700,000 shares. How does Organon & Co.'s short interest compare to its competitors? 6.46% of Organon & Co.'s shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Organon & Co.: Genmab A/S (0.26%), Intra-Cellular Therapies, Inc. (1.50%), Viatris Inc. (2.60%), Moderna, Inc. (11.84%), Dr. Reddy's Laboratories Limited (1.90%), Vaxcyte, Inc. (10.86%), Sarepta Therapeutics, Inc. (5.29%), Qiagen (1.18%), Ascendis Pharma A/S (5.42%), Roivant Sciences Ltd. (9.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Organon & Co. stock? Short selling OGN is an investing strategy that aims to generate trading profit from Organon & Co. as its price is falling. OGN shares are trading up $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Organon & Co.? A short squeeze for Organon & Co. occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OGN, which in turn drives the price of the stock up even further. How often is Organon & Co.'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OGN, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Genmab A/S Short Interest Intra-Cellular Therapies Short Interest Viatris Short Interest Moderna Short Interest Dr. Reddy's Laboratories Short Interest Vaxcyte Short Interest Sarepta Therapeutics Short Interest Qiagen Short Interest Ascendis Pharma A/S Short Interest Roivant Sciences Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:OGN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organon & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organon & Co. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OGN Stock Alerts